Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Revive Therapeutics Ltd (RVV.CN)

Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Revive Therapeutics Ltd 82 Richmond Street East The Canadian Venture Building Toronto ON M5C 1P1 CAN

https://www.revivethera.com P: 888-901-0036

Description:

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various program.

Key Statistics

Overview:

Market Capitalization, $K 4,186
Shares Outstanding, K 418,564
Annual Sales, $ 0 K
Annual Net Income, $ -5,619 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -473 K
60-Month Beta 1.24
% of Institutional Shareholders 0.55%

Growth:

1-Year Return -71.43%
3-Year Return -97.06%
5-Year Return -81.82%
5-Year Revenue Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 11/29/24
Next Earnings Date N/A
Earnings Per Share ttm -0.01
EPS Growth vs. Prev Year -62.58%
Dividend Payout Ratio 0.00%

RVV.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -66.98%
Return-on-Assets % -47.85%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 0.62
Book Value/Share 0.02
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar